Mycronic AB (MIL:1MYCR)
€ 29.32 (0%) Market Cap: 6.03 Bil Enterprise Value: 5.82 Bil PE Ratio: 38.56 PB Ratio: 8.49 GF Score: 73/100

Q2 2026 Mycronic AB (publ) Earnings Call Transcript

Jul 14, 2026 / 08:00AM GMT
Release Date Price: €26.9

Key Points

Positve
  • Record order intake increased by 119%, reaching 2.9 billion SEK.
  • Strong contributions from all divisions, particularly Global Technologies and High Volume.
  • Gross margin improved to 57% with EBIT close to 700 million SEK, representing 29%.
  • Order backlog increased to 5.25 billion SEK, providing a solid foundation for future growth.
  • Revised full-year outlook upwards by half a billion to 9.25 billion SEK due to strong business momentum.
Negative
  • PCB Assembly Solutions continues to make a loss, with a negative EBIT of 44 million SEK.
  • Restructuring costs of 39 million SEK impacted PCB Assembly Solutions' financials.
  • High lead times in PCB test, with delivery capacity constraints impacting order fulfillment.
  • Currency fluctuations have a minor impact on financial performance.
  • R&D spending remains high, with no immediate reduction expected, impacting short-term profitability.
Sven Chetkovich;publ;Director;Investor Relations
Mycronic AB

()--

Hello and welcome to the presentation of Micronik's Q2 report. My name is Sven Cetkovic. I'm the Director of Investor Relations at Micronik.

And with me, I have Micronik's CEO Anders Linkvist and CFO Pierre Bruson, who will be presenting today.

And with that, I hand over to Anders. Please go ahead and present Micronik's Q2 report.

Anders Lindqvist;publ;President
Mycronic AB;Chief Executive Officer

()- -

Thank you, Sven, and good morning, everyone. So today we have the standard agenda. So talk about the Q2 in general, in short, go deeper in the different divisions. Pierre will talk about the financials, some words on sustainability, and we end the session with the question-and-answer session. And as usually in the material that is on the website, you also have the.

The market update, which we will not present, but it's there for information.

So just to summarize the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot